Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2015, Article ID 798936, 8 pages
http://dx.doi.org/10.1155/2015/798936
Research Article

Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry

1Worldwide Medicinal Chemistry, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USA
2Oncology Research Unit, Pfizer, Inc., La Jolla Laboratories, 10770 Science Center Drive, San Diego, CA 92121, USA

Received 29 June 2015; Revised 2 October 2015; Accepted 20 October 2015

Academic Editor: Pavel Hozak

Copyright © 2015 Michael J. Greig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Wong, S. H. Bigner, D. D. Bigner, K. W. Kinzler, S. R. Hamilton, and B. Vogelstein, “Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 19, pp. 6899–6903, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. L. V. Sequist, J. C.-H. Yang, N. Yamamoto et al., “Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations,” Journal of Clinical Oncology, vol. 31, no. 27, pp. 3327–3334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Gonzales, K. E. Hook, I. W. Althaus et al., “Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor,” Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 1880–1889, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. E. Cross, S. E. Ashton, S. Ghiorghiu et al., “AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer,” Cancer Discovery, vol. 4, no. 9, pp. 1046–1061, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. O. Walter, R. T. T. Sjin, H. J. Haringsma et al., “Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M mediated resistance in NSCLC,” Cancer Discovery, vol. 3, no. 12, pp. 1404–1415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. R. Kristensen, J. Gsponer, and L. J. Foster, “Protein synthesis rate is the predominant regulator of protein expression during differentiation,” Molecular Systems Biology, vol. 9, p. 689, 2013. View at Google Scholar · View at Scopus
  7. H. Eagle, K. A. Piez, R. Fleischman, and V. I. Oyama, “Protein turnover in mammaliar cell cultures,” Journal of Biological Chemistry, vol. 234, no. 3, pp. 592–597, 1959. View at Google Scholar · View at Scopus
  8. S.-E. Ong, B. Blagoev, I. Kratchmarova et al., “Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics,” Molecular & Cellular Proteomics, vol. 1, no. 5, pp. 376–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Pratt, J. Petty, I. Riba-Garcia et al., “Dynamics of protein turnover, a missing dimension in proteomics,” Molecular & Cellular Proteomics, vol. 1, no. 8, pp. 579–591, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. P. Oksvold, N. M. Pedersen, L. Forfang, and E. B. Smeland, “Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling,” FEBS Letters, vol. 586, no. 20, pp. 3575–3581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. F. M. Boisvert, Y. Ahmad, M. Gierliński et al., “A quantitative spatial proteomics analysis of proteome turnover in human cells,” Molecular & Cellular Proteomics, vol. 11, no. 3, Article ID M111.011429, 2012. View at Publisher · View at Google Scholar
  12. S. Bhatt, Z. Xiao, Z. Meng, and B. S. Katzenellenbogen, “Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCFskp2 proteasomal complex,” Molecular and Cellular Biology, vol. 32, no. 10, pp. 1928–1943, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Zhou, K. Jeyaraman, P. Yusoff, and S. Shenolikar, “Phosphorylation at tyrosine 262 promotes GADD34 protein turnover,” The Journal of Biological Chemistry, vol. 288, no. 46, pp. 33146–33155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. P. G. Ulery, G. Rudenko, and E. J. Nestler, “Regulation of ΔFosB stability by phosphorylation,” Journal of Neuroscience, vol. 26, no. 19, pp. 5131–5142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. L. K. Goh and A. Sorkin, “Endocytosis of receptor tyrosine kinases,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 5, Article ID a017459, 2013. View at Google Scholar · View at Scopus
  16. K. A. Grako, J. M. Olefsky, and D. A. McClain, “Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors,” Endocrinology, vol. 130, no. 6, pp. 3441–3452, 1992. View at Google Scholar · View at Scopus
  17. C. M. Stoscheck and G. Carpenter, “Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells,” Journal of Cellular Physiology, vol. 120, no. 3, pp. 296–302, 1984. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sigismund, E. Argenzio, D. Tosoni, E. Cavallaro, S. Polo, and P. P. Di Fiore, “Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation,” Developmental Cell, vol. 15, no. 2, pp. 209–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. D. Davies and T. J. Humphrey, “Amino acid recycling in relation to protein turnover,” Plant Physiology, vol. 61, no. 1, pp. 54–58, 1978. View at Publisher · View at Google Scholar
  20. S. B. Cambridge, F. Gnad, C. Nguyen, J. L. Bermejo, M. Krüger, and M. Mann, “Systems-wide proteomic analysis in mammalian cells reveals conserved, functional protein turnover,” Journal of Proteome Research, vol. 10, no. 12, pp. 5275–5284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. Burke and H. S. Wiley, “Human mammary epithelial cells rapidly exchange empty EGFR between surface and intracellular pools,” Journal of Cellular Physiology, vol. 180, no. 3, pp. 448–460, 1999. View at Google Scholar · View at Scopus
  22. H. S. Wiley, J. J. Herbst, B. J. Walsh, D. A. Lauffenburger, M. G. Rosenfeld, and G. N. Gill, “The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor,” Journal of Biological Chemistry, vol. 266, no. 17, pp. 11083–11094, 1991. View at Google Scholar · View at Scopus
  23. C. M. Stoscheck and G. Carpenter, “Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts,” Journal of Cell Biology, vol. 98, no. 3, pp. 1048–1053, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Wang, O. Roche, M. S. Yan et al., “Regulation of endocytosis via the oxygen-sensing pathway,” Nature Medicine, vol. 15, no. 3, pp. 319–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. P. Gully, F. Zhang, J. Chen et al., “Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer,” Molecular Cancer, vol. 9, article 42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Fierro-Monti, J. Racle, C. Hernandez, P. Waridel, V. Hatzimanikatis, and M. Quadroni, “A novel pulse-chase SILAC strategy measures changes in protein decay and synthesis rates induced by perturbation of proteostasis with an Hsp90 inhibitor,” PLoS ONE, vol. 8, no. 11, Article ID e80423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Sorkin and C. M. Waters, “Endocytosis of growth factor receptors,” BioEssays, vol. 15, no. 6, pp. 375–382, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Ebner and R. Derynck, “Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes,” Cell Regulation, vol. 2, no. 8, pp. 599–612, 1991. View at Google Scholar · View at Scopus
  29. Y.-R. Chen, Y.-N. Fu, C.-H. Lin et al., “Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants,” Oncogene, vol. 25, no. 8, pp. 1205–1215, 2005. View at Publisher · View at Google Scholar · View at Scopus